Here, we identified a key disease mechanism for TAB2 deficiency–induced dilated cardiomyopathy, which involves aberrant RIPK1 activation and the induction of RIPK1-dependent apoptosis and necroptosis. Here, RIPK1 is linked to dilated cardiomyopathy.